NCT05734651

Brief Summary

A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medical (Austria) are used. Those implants are undergoing constant development and improvement. To guarantee their clinical performance, this clinical study is evaluating safety and efficacy of all implants produced by Falcon Medical. The purpose of this study is to evaluate the effcacy and safety of implants produced and distributed by Falcon Medical. All patients with primary THA and usage of a Falcon Medical implant are included. The outcome measures include intra-operative complications, early post-operative complications, revision for any cause and patient reported outcome (WOMAC questionnaire). All data is prospectively collected in a standardized fashion.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
192mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Feb 2023Feb 2042

First Submitted

Initial submission to the registry

February 9, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

February 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2026

Completed
16 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2042

Expected
Last Updated

February 21, 2023

Status Verified

February 1, 2023

Enrollment Period

3 years

First QC Date

February 9, 2023

Last Update Submit

February 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stem Migration

    Stem Migration measured with the validated EBRA method. The stem migration is assessed in millimeters. The radiograph before surgery and sequential radiographs after surgery are assessed.

    20 years

Secondary Outcomes (1)

  • WOMAC Score

    20 years

Study Arms (1)

Intervention

Device: PROMIS Stem

Interventions

Primary Total Hip Arthroplasty with the PROMIS Stem (Fa. Falcon Medical, Mödling, Austria)

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient treated with primary total hip arthroplasty at this department are included.

You may qualify if:

  • Primary total hip arthroplasty with the PROMIS stem

You may not qualify if:

  • n/a

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BKH St. Johann in Tirol, Department for Orthopedics and Traumatology

Sankt Johann in Tirol, Tyrol, 6380, Austria

RECRUITING

Related Publications (1)

  • Wagner M, Neururer S, Dammerer D, Nardelli P, Kaufmann G, Braito M, Brunner A. External validation of the Tyrolean hip arthroplasty registry. J Exp Orthop. 2022 Aug 30;9(1):87. doi: 10.1186/s40634-022-00526-3.

MeSH Terms

Conditions

Osteoarthritis, HipLegg-Calve-Perthes DiseaseOsteonecrosisFemoral Neck Fractures

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesFemur Head NecrosisBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsHip FracturesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Central Study Contacts

Moritz Wagner, MD

CONTACT

Hannes Schönthaler, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

February 9, 2023

Primary Completion

February 9, 2026

Study Completion (Estimated)

February 9, 2042

Last Updated

February 21, 2023

Record last verified: 2023-02

Locations